Synergic action of COVID-19 patients’ plasma and hypoxia was needed to promote CD39 mRNA overexpression (Supplementary Figure 2D) as well as elevated expression of CD39 in CD4+, CD8+ T cells and CD16+ NK cells (Supplementary Figure 2E). The gene discussed is CD4; the disease is COVID-19.